Novakand Pharma AB (publ) (STO:NOVKAN)
0.1400
+0.0130 (10.24%)
Jan 21, 2026, 5:29 PM CET
-86.41% (1Y)
| Market Cap | 15.39M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -51.90M |
| Shares Out | 121.19M |
| EPS (ttm) | -0.43 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 573,659 |
| Average Volume | 632,282 |
| Open | 0.1252 |
| Previous Close | 0.1270 |
| Day's Range | 0.1252 - 0.1510 |
| 52-Week Range | 0.1210 - 2.2500 |
| Beta | 1.10 |
| RSI | 41.31 |
| Earnings Date | Feb 20, 2026 |